Trials / Unknown
UnknownNCT03383471
The Efficacy and Safety of Invossa K Injection in Patients Diagnosed With Knee Osteoarthritis
A Multicenter, Randomized, Placebo Controlled, Double-blind, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Invossa K Injection in Patients Diagnosed as Knee Osteoarthritis With Kellgren & Lawrence Grade 2
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 146 (estimated)
- Sponsor
- Kolon Life Science · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of intraarticular Invossa K Injection patients diagnosed with Kellgren \& Lawrence grade 2 knee osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Invossa K Inj. | Invossa K Inj. |
| DRUG | Placebo | Placebo control |
Timeline
- Start date
- 2018-02-12
- Primary completion
- 2019-12-31
- Completion
- 2020-03-30
- First posted
- 2017-12-26
- Last updated
- 2018-03-07
Locations
17 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03383471. Inclusion in this directory is not an endorsement.